Organization · Venture Capital
Panakes Partners
Panakes Partners is a venture capital firm based in Milan, Italy, specializing in early-stage investments in life sciences companies across Europe and Israel. The firm focuses on innovative technologies that address significant medical needs.
Overview
What Panakes Partners does
What Panakes Partners is
Panakes Partners is a venture capital firm based in Milan, Italy, specializing in early-stage investments in life sciences companies across Europe and Israel. The firm focuses on innovative technologies that address significant medical needs.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- March 7, 2026
Official channels
Find Panakes Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Panakes Partners as a funder
Investment thesis
Panakès Partners is dedicated to investing in life sciences companies that address significant medical needs, focusing on early-stage startups and SMEs with innovative products.
Focus narrative
The firm invests in life sciences technologies that improve or solve health conditions, targeting ambitious early-stage startups and SMEs. Panakès Partners emphasizes collaboration with clinicians and industry experts to enhance the development of its portfolio companies, while integrating environmental, social, and governance (ESG) principles into its investment processes.
Value beyond capital
Panakès Partners provides both financial and business support to its portfolio companies, leveraging a strong network of clinicians and industry experts to accelerate their development. The firm is committed to integrating ESG principles into its investment processes, ensuring that its investments not only yield financial returns but also contribute positively to society.
Terms and economics
- Typical check
- $3,000,000–$8,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Panakès Partners has a diverse portfolio that includes companies and technologies across various medical fields, such as dermatology (Atopic Dermatitis), surgery (Surgical Smoke Removal), ophthalmology (Presbyopia), cardiovascular (Tricuspid Therapy, Microvascular Obstruction, Mitral Valve Replacement, Lymphedema Treatment), oncology (Nuclear Medicine, Blood Brain Barrier Opening, Oncology Vaccine), biotech (Age-Related Macular Degeneration, Respiratory Diseases), in-vitro diagnostics (Sepsis, Alzheimer), neuromodulation (Tinnitus, Migraine), and regenerative medicine (Breast Reconstruction and Augmentation).
Common questions
What to know about Panakes Partners
Upseed classifies Panakes Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 7, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.